IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-34871-9.html
   My bibliography  Save this article

ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression

Author

Listed:
  • Ni Li

    (University of Chinese Academy of Sciences)

  • Qiuli Liu

    (Army Medical University)

  • Ying Han

    (University of Chinese Academy of Sciences)

  • Siyu Pei

    (University of Chinese Academy of Sciences)

  • Bisheng Cheng

    (Sun Yat-sen Memorial Hospital, Sun Yat-sen University)

  • Junyu Xu

    (Chinese Academy of Sciences)

  • Xiang Miao

    (University of Chinese Academy of Sciences)

  • Qiang Pan

    (University of Chinese Academy of Sciences)

  • Hanling Wang

    (University of Chinese Academy of Sciences)

  • Jiacheng Guo

    (University of Chinese Academy of Sciences)

  • Xuege Wang

    (University of Chinese Academy of Sciences)

  • Guoying Zhang

    (University of Chinese Academy of Sciences)

  • Yannan Lian

    (University of Chinese Academy of Sciences)

  • Wei Zhang

    (University of Chinese Academy of Sciences)

  • Yi Zang

    (University of Chinese Academy of Sciences)

  • Minjia Tan

    (Chinese Academy of Sciences)

  • Qintong Li

    (Sichuan University)

  • Xiaoming Wang

    (Nanjing Medical University)

  • Yichuan Xiao

    (University of Chinese Academy of Sciences)

  • Guohong Hu

    (University of Chinese Academy of Sciences)

  • Jun Jiang

    (Army Medical University)

  • Hai Huang

    (Sun Yat-sen Memorial Hospital, Sun Yat-sen University)

  • Jun Qin

    (University of Chinese Academy of Sciences
    Army Medical University)

Abstract

Chronic inflammation and an immunosuppressive microenvironment promote prostate cancer (PCa) progression and diminish the response to immune checkpoint blockade (ICB) therapies. However, it remains unclear how and to what extent these two events are coordinated. Here, we show that ARID1A, a subunit of the SWI/SNF chromatin remodeling complex, functions downstream of inflammation-induced IKKβ activation to shape the immunosuppressive tumor microenvironment (TME). Prostate-specific deletion of Arid1a cooperates with Pten loss to accelerate prostate tumorigenesis. We identify polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) as the major infiltrating immune cell type that causes immune evasion and reveal that neutralization of PMN-MDSCs restricts the progression of Arid1a-deficient tumors. Mechanistically, inflammatory cues activate IKKβ to phosphorylate ARID1A, leading to its degradation via β-TRCP. ARID1A downregulation in turn silences the enhancer of A20 deubiquitinase, a critical negative regulator of NF-κB signaling, and thereby unleashes CXCR2 ligand-mediated MDSC chemotaxis. Importantly, our results support the therapeutic strategy of anti-NF-κB antibody or targeting CXCR2 combined with ICB for advanced PCa. Together, our findings highlight that the IKKβ/ARID1A/NF-κB feedback axis integrates inflammation and immunosuppression to promote PCa progression.

Suggested Citation

  • Ni Li & Qiuli Liu & Ying Han & Siyu Pei & Bisheng Cheng & Junyu Xu & Xiang Miao & Qiang Pan & Hanling Wang & Jiacheng Guo & Xuege Wang & Guoying Zhang & Yannan Lian & Wei Zhang & Yi Zang & Minjia Tan , 2022. "ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
  • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-34871-9
    DOI: 10.1038/s41467-022-34871-9
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-34871-9
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-022-34871-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Jun Qin & San-Pin Wu & Chad J. Creighton & Fangyan Dai & Xin Xie & Chiang-Min Cheng & Anna Frolov & Gustavo Ayala & Xia Lin & Xin-Hua Feng & Michael M. Ittmann & Shaw-Jenq Tsai & Ming-Jer Tsai & Sophi, 2013. "COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis," Nature, Nature, vol. 493(7431), pages 236-240, January.
    2. Xin Lu & James W. Horner & Erin Paul & Xiaoying Shang & Patricia Troncoso & Pingna Deng & Shan Jiang & Qing Chang & Denise J. Spring & Padmanee Sharma & John A. Zebala & Dean Y. Maeda & Y. Alan Wang &, 2017. "Erratum: Effective combinatorial immunotherapy for castration-resistant prostate cancer," Nature, Nature, vol. 545(7652), pages 116-116, May.
    3. Zhihu Ding & Chang-Jiun Wu & Gerald C. Chu & Yonghong Xiao & Dennis Ho & Jingfang Zhang & Samuel R. Perry & Emma S. Labrot & Xiaoqiu Wu & Rosina Lis & Yujin Hoshida & David Hiller & Baoli Hu & Shan Ji, 2011. "SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression," Nature, Nature, vol. 470(7333), pages 269-273, February.
    4. Zhenbang Chen & Lloyd C. Trotman & David Shaffer & Hui-Kuan Lin & Zohar A. Dotan & Masaru Niki & Jason A. Koutcher & Howard I. Scher & Thomas Ludwig & William Gerald & Carlos Cordon-Cardo & Pier Paolo, 2005. "Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis," Nature, Nature, vol. 436(7051), pages 725-730, August.
    5. Joanna Cyrta & Anke Augspach & Maria Rosaria Filippo & Davide Prandi & Phillip Thienger & Matteo Benelli & Victoria Cooley & Rohan Bareja & David Wilkes & Sung-Suk Chae & Paola Cavaliere & Noah Dephou, 2020. "Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity," Nature Communications, Nature, vol. 11(1), pages 1-16, December.
    6. Vincenzo Bronte & Sven Brandau & Shu-Hsia Chen & Mario P. Colombo & Alan B. Frey & Tim F. Greten & Susanna Mandruzzato & Peter J. Murray & Augusto Ochoa & Suzanne Ostrand-Rosenberg & Paulo C. Rodrigue, 2016. "Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards," Nature Communications, Nature, vol. 7(1), pages 1-10, November.
    7. Qiuhui Li & Qu Deng & Hsueh-Ping Chao & Xin Liu & Yue Lu & Kevin Lin & Bigang Liu & Gregory W. Tang & Dingxiao Zhang & Amanda Tracz & Collene Jeter & Kiera Rycaj & Tammy Calhoun-Davis & Jiaoti Huang &, 2018. "Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses," Nature Communications, Nature, vol. 9(1), pages 1-17, December.
    8. Xin Lu & James W. Horner & Erin Paul & Xiaoying Shang & Patricia Troncoso & Pingna Deng & Shan Jiang & Qing Chang & Denise J. Spring & Padmanee Sharma & John A. Zebala & Dean Y. Maeda & Y. Alan Wang &, 2017. "Effective combinatorial immunotherapy for castration-resistant prostate cancer," Nature, Nature, vol. 543(7647), pages 728-732, March.
    9. Arianna Calcinotto & Clarissa Spataro & Elena Zagato & Diletta Di Mitri & Veronica Gil & Mateus Crespo & Gaston De Bernardis & Marco Losa & Michela Mirenda & Emiliano Pasquini & Andrea Rinaldi & Semin, 2018. "IL-23 secreted by myeloid cells drives castration-resistant prostate cancer," Nature, Nature, vol. 559(7714), pages 363-369, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Marco Bolis & Daniela Bossi & Arianna Vallerga & Valentina Ceserani & Manuela Cavalli & Daniela Impellizzieri & Laura Di Rito & Eugenio Zoni & Simone Mosole & Angela Rita Elia & Andrea Rinaldi & Ricar, 2021. "Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    2. Anwaar Saeed & Robin Park & Harsh Pathak & Ayah Nedal Al-Bzour & Junqiang Dai & Milind Phadnis & Raed Al-Rajabi & Anup Kasi & Joaquina Baranda & Weijing Sun & Stephen Williamson & Yu-Chiao Chiu & Hati, 2024. "Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort," Nature Communications, Nature, vol. 15(1), pages 1-13, December.
    3. Dhivya Sridaran & Surbhi Chouhan & Kiran Mahajan & Arun Renganathan & Cody Weimholt & Shambhavi Bhagwat & Melissa Reimers & Eric H. Kim & Manish K. Thakur & Muhammad A. Saeed & Russell K. Pachynski & , 2022. "Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance," Nature Communications, Nature, vol. 13(1), pages 1-21, December.
    4. Weili Ma & Maria Cecília Oliveira-Nunes & Ke Xu & Andrew Kossenkov & Benjamin C. Reiner & Richard C. Crist & James Hayden & Qing Chen, 2023. "Type I interferon response in astrocytes promotes brain metastasis by enhancing monocytic myeloid cell recruitment," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    5. Michael Fraser & Julie Livingstone & Jeffrey L. Wrana & Antonio Finelli & Housheng Hansen He & Theodorus van der Kwast & Alexandre R. Zlotta & Robert G. Bristow & Paul C. Boutros, 2021. "Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    6. Won Kyung Kim & Alyssa J. Buckley & Dong-Hoon Lee & Alex Hiroto & Christian H. Nenninger & Adam W. Olson & Jinhui Wang & Zhuo Li & Rajeev Vikram & Yao Mawulikplimi Adzavon & Tak-yu Yau & Yigang Bao & , 2024. "Androgen deprivation induces double-null prostate cancer via aberrant nuclear export and ribosomal biogenesis through HGF and Wnt activation," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    7. Qiming Zhou & Yao Peng & Fenfen Ji & Huarong Chen & Wei Kang & Lam-Shing Chan & Hongyan Gou & Yufeng Lin & Pingmei Huang & Danyu Chen & Qinyao Wei & Hao Su & Cong Liang & Xiang Zhang & Jun Yu & Chi Ch, 2023. "Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    8. Saeed Daneshmandi & Jee Eun Choi & Qi Yan & Cameron R. MacDonald & Manu Pandey & Mounika Goruganthu & Nathan Roberts & Prashant K. Singh & Richard M. Higashi & Andrew N. Lane & Teresa W-M. Fan & Jianm, 2024. "Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    9. Silvia Tiberti & Carlotta Catozzi & Ottavio Croci & Mattia Ballerini & Danilo Cagnina & Chiara Soriani & Caterina Scirgolea & Zheng Gong & Jiatai He & Angeli D. Macandog & Amir Nabinejad & Carina B. N, 2022. "GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    10. Nader Al-Nakouzi & Chris Kedong Wang & Htoo Zarni Oo & Irina Nelepcu & Nada Lallous & Charlotte B. Spliid & Nastaran Khazamipour & Joey Lo & Sarah Truong & Colin Collins & Desmond Hui & Shaghayegh Esf, 2022. "Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    11. Martina Troiani & Manuel Colucci & Mariantonietta D’Ambrosio & Ilaria Guccini & Emiliano Pasquini & Angelica Varesi & Aurora Valdata & Simone Mosole & Ajinkya Revandkar & Giuseppe Attanasio & Andrea R, 2022. "Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    12. Raquel S. Pereira & Rahul Kumar & Alessia Cais & Lara Paulini & Alisa Kahler & Jimena Bravo & Valentina R. Minciacchi & Theresa Krack & Eric Kowarz & Costanza Zanetti & Parimala Sonika Godavarthy & Fa, 2023. "Distinct and targetable role of calcium-sensing receptor in leukaemia," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    13. Huiqiang Cai & Bin Zhang & Johanne Ahrenfeldt & Justin V. Joseph & Maria Riedel & Zongliang Gao & Sofie K. Thomsen & Ditte S. Christensen & Rasmus O. Bak & Henrik Hager & Mikkel H. Vendelbo & Xin Gao , 2024. "CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    14. Sukanya Panja & Mihai Ioan Truica & Christina Y. Yu & Vamshi Saggurthi & Michael W. Craige & Katie Whitehead & Mayra V. Tuiche & Aymen Al-Saadi & Riddhi Vyas & Shridar Ganesan & Suril Gohel & Frederic, 2024. "Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC," Nature Communications, Nature, vol. 15(1), pages 1-24, December.
    15. Yanan Tang & Turun Song & Lu Gao & Saifu Yin & Ming Ma & Yun Tan & Lijuan Wu & Yang Yang & Yanqun Wang & Tao Lin & Feng Li, 2022. "A CRISPR-based ultrasensitive assay detects attomolar concentrations of SARS-CoV-2 antibodies in clinical samples," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    16. Jing Wang & Ramon Ocadiz-Ruiz & Matthew S. Hall & Grace G. Bushnell & Sophia M. Orbach & Joseph T. Decker & Ravi M. Raghani & Yining Zhang & Aaron H. Morris & Jacqueline S. Jeruss & Lonnie D. Shea, 2023. "A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungs," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    17. J. K. Wiencke & Annette M. Molinaro & Gayathri Warrier & Terri Rice & Jennifer Clarke & Jennie W. Taylor & Margaret Wrensch & Helen Hansen & Lucie McCoy & Emily Tang & Stan J. Tamaki & Courtney M. Tam, 2022. "DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    18. Vipul Bhatia & Nikhil V. Kamat & Tiffany E. Pariva & Li-Ting Wu & Annabelle Tsao & Koichi Sasaki & Huiyun Sun & Gerardo Javier & Sam Nutt & Ilsa Coleman & Lauren Hitchcock & Ailin Zhang & Dmytro Rudoy, 2023. "Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-23, December.
    19. Lauriane Galle-Treger & Doumet Georges Helou & Christine Quach & Emily Howard & Benjamin P. Hurrell & German R. Aleman Muench & Pedram Shafiei-Jahani & Jacob D. Painter & Andrea Iorga & Lily Dara & Ju, 2022. "Autophagy impairment in liver CD11c+ cells promotes non-alcoholic fatty liver disease through production of IL-23," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    20. Vincenzo Salemme & Mauro Vedelago & Alessandro Sarcinella & Federico Moietta & Alessio Piccolantonio & Enrico Moiso & Giorgia Centonze & Marta Manco & Andrea Guala & Alessia Lamolinara & Costanza Ange, 2023. "p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response," Nature Communications, Nature, vol. 14(1), pages 1-22, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-34871-9. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.